Literature DB >> 8955512

Cellular and subcellular localization of delta opioid receptor immunoreactivity in the rat dentate gyrus.

K G Commons1, T A Milner.   

Abstract

To study a potential locus of action of opioids in the rat dentate gyrus, we examined the localization of the delta opioid receptor (DOR) by immunocytochemistry. Two antisera raised to unique, non-overlapping peptide sequences located within the extracellular N-terminal sequence of DOR were tested. By light microscopy, numerous neurons in the central hilar region were intensely labeled for DOR, while the granule cell layer contained light DOR immunoreactivity. To further characterize hilar neuron cell types which contained DOR, sections through the dentate gyrus were double labeled using immunofluorescence with antisera to DOR and either gamma-aminobutyric acid (GABA), neuropeptide Y (NPY), or somatostatin-28 antisera. Most DOR-labeled perikarya also contained GABA and NPY, while a subpopulation contained somatostatin. Electron microscopic examination of sections labeled for DOR revealed that the immunoreactivity was common in profiles which exhibited the morphological characteristics of granule cells, as well as those of non-granule cells. DOR immunoreactivity was located at postsynaptic sites within neuronal perikarya (2%), dendrites (27%), and dendritic spines (22%); as well as in presynaptic axon terminals (25%) and glia (23%) (n = 279). In dendrites and dendritic spines, DOR immunoreactivity was most often associated with the plasmalemmal surface near asymmetric synapses. In axon terminals, DOR immunoreactivity primarily surrounded small, clear vesicles, and was less consistently found on the plasmalemmal surface. The distribution of DOR-labeled profiles overlapped with, but was not restricted to regions known to contain enkephalin. These data suggest that opiates acting at the DOR can modulate both hilar neurons and granule cells both pre- and postsynaptically.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8955512     DOI: 10.1016/s0006-8993(96)00774-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  17 in total

1.  Delta opioid receptors colocalize with corticotropin releasing factor in hippocampal interneurons.

Authors:  T J Williams; T A Milner
Journal:  Neuroscience       Date:  2011-01-26       Impact factor: 3.590

Review 2.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

3.  Cellular sites for activation of delta-opioid receptors in the rat nucleus accumbens shell: relationship with Met5-enkephalin.

Authors:  A L Svingos; C L Clarke; V M Pickel
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

Review 4.  Hippocampal GABAergic Inhibitory Interneurons.

Authors:  Kenneth A Pelkey; Ramesh Chittajallu; Michael T Craig; Ludovic Tricoire; Jason C Wester; Chris J McBain
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

5.  Sex Differences in the Rat Hippocampal Opioid System After Oxycodone Conditioned Place Preference.

Authors:  James D Ryan; Yan Zhou; Natalina H Contoreggi; Farah K Bshesh; Jason D Gray; Joshua F Kogan; Konrad T Ben; Bruce S McEwen; Mary Jeanne Kreek; Teresa A Milner
Journal:  Neuroscience       Date:  2018-10-11       Impact factor: 3.590

6.  Preferential cytoplasmic localization of delta-opioid receptors in rat striatal patches: comparison with plasmalemmal mu-opioid receptors.

Authors:  H Wang; V M Pickel
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

7.  Hormonal regulation of delta opioid receptor immunoreactivity in interneurons and pyramidal cells in the rat hippocampus.

Authors:  Tanya J Williams; Annelyn Torres-Reveron; Jeanette D Chapleau; Teresa A Milner
Journal:  Neurobiol Learn Mem       Date:  2011-01-09       Impact factor: 2.877

8.  Endogenous activation of mu and delta-1 opioid receptors is required for long-term potentiation induction in the lateral perforant path: dependence on GABAergic inhibition.

Authors:  C R Bramham; J M Sarvey
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

9.  Ovarian hormones influence corticotropin releasing factor receptor colocalization with delta opioid receptors in CA1 pyramidal cell dendrites.

Authors:  Tanya J Williams; Keith T Akama; Margarete G Knudsen; Bruce S McEwen; Teresa A Milner
Journal:  Exp Neurol       Date:  2011-04-29       Impact factor: 5.330

10.  Mouse δ opioid receptors are located on presynaptic afferents to hippocampal pyramidal cells.

Authors:  Xavier Rezaï; Lauren Faget; Ewa Bednarek; Yannick Schwab; Brigitte L Kieffer; Dominique Massotte
Journal:  Cell Mol Neurobiol       Date:  2012-01-18       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.